Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer

被引：0
作者：
Son, Ji [1 ]
Cain, Katherine E. [2 ]
Marten, Claire A. [2 ]
Dwyer, Kaitlin W. [1 ]
Sims, Travis T. [1 ]
Taylor, Jolyn S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pharm Clin Programs, Houston, TX USA
来源：
GYNECOLOGIC ONCOLOGY REPORTS | 2024年 / 56卷
关键词：
SQUAMOUS-CELL-CARCINOMA; PREVIOUSLY TREATED RECURRENT; PHASE-II; TISSUE FACTOR; PERSISTENT; TRIAL;
D O I：
10.1016/j.gore.2024.101525
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Recurrent or primary metastatic cervical cancer: current and future treatments
    Gennigens, C.
    Jerusalem, G.
    Lapaille, L.
    De Cuypere, M.
    Streel, S.
    Kridelka, F.
    Ray-Coquard, I
    ESMO OPEN, 2022, 7 (05)
  • [22] Recurrent cervical cancer - therapeutic options
    Zolciak-Siwinska, Agnieszka
    Jonska-Gmyrek, Joanna
    Socha, Joanna
    GINEKOLOGIA POLSKA, 2012, 83 (07) : 527 - 531
  • [23] Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer
    Hasegawa, Kosei
    Takahashi, Shunji
    Ushijima, Kimio
    Okadome, Masao
    Yonemori, Kan
    Yokota, Harushige
    Vergote, Ignace
    Monk, Bradley J.
    Tewari, Krishnansu S.
    Fujiwara, Keiichi
    Li, Jingjin
    Jamil, Shaheda
    Paccaly, Anne
    Takehara, Kazuhiro
    Usami, Tomoka
    Aoki, Yoichi
    Suzuki, Nao
    Kobayashi, Yoichi
    Yoshida, Yoshio
    Watari, Hidemichi
    Seebach, Frank
    Lowy, Israel
    Mathias, Melissa
    Fury, Matthew G.
    Oaknin, Ana
    CANCER MEDICINE, 2024, 13 (18):
  • [24] Molecular landscape of recurrent cervical cancer
    Adiga, Divya
    Eswaran, Sangavi
    Pandey, Deeksha
    Sharan, Krishna
    Kabekkodu, Shama Prasada
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [25] Chemotherapy for advanced or recurrent cervical cancer
    Kamura, Toshiharu
    Ushijima, Kimio
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (02): : 161 - 164
  • [26] Metastatic or recurrent cervical cancer/treatment
    Kurtz, Jean-Emmanuel
    D'Hondt, Veronique
    Lecuru, Fabrice
    Lhomme, Catherine
    BULLETIN DU CANCER, 2017, 104 : S39 - S42
  • [27] Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
    Son, Ji
    Lin, Heather Y.
    Fu, Siqing
    Biter, Amadeo B.
    Dumbrava, Ecaterina E.
    Karp, Daniel D.
    Naing, Aung
    Pant, Shubham
    Piha-Paul, Sarina A.
    Rodon, Jordi
    Subbiah, Vivek
    Tsimberidou, Apostolia M.
    Yap, Timothy A.
    Frumovitz, Michael M.
    Jazaeri, Amir A.
    Ramirez, Pedro T.
    Westin, Shannon N.
    Yuan, Ying
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (01) : 10 - 18
  • [28] A Multimodality Treatment Approach for the Management of Recurrent Cervical Cancer in an Elderly Female Patient: A Case Report
    Jules, Manishimwe
    Rahul, Neha
    Weerarathna, Induni N.
    Luharia, Anurag
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [29] Management of recurrent cervical cancer. Review of the literature and case report
    Elst, Ph.
    Ahankour, F.
    Tjalma, W.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (06) : 435 - 441
  • [30] The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy
    Mabuchi, Seiji
    Morishige, Kenichirou
    Fujita, Masami
    Tsutsui, Tateki
    Sakata, Masahiro
    Enomoto, Takayuki
    Kimura, Tadashi
    GYNECOLOGIC ONCOLOGY, 2009, 113 (02) : 200 - 204
12345